Linked Life Data

19830399

Source:http://linkedlifedata.com/resource/pubmed/id/19830399

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2010-1-29
pubmed:abstractText
Stroke is still the leading cause of long-term major disability in developed countries, although several improvements have been achieved in acute stroke therapy (e.g. thrombolysis, stroke-unit treatment,etc.). Therefore, an effective secondary prevention - guided by the etiology and risk factors of stroke - is of particular importance to reduce stroke morbidity. Recently, two important studies (SPARCL and PRoFESS) analyzed the significance of statin therapy as well as the efficacy of different antiplatelet therapies for secondary stroke prevention. In this review we summarize the results and discuss the implications of these findings - including the most recent data - for stroke prevention.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1432-1289
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1227-38
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
[Secondary prevention of stroke according to PRoFESS and SPARCL].
pubmed:affiliation
Neurologische Klinik, Medical Park, Thanngasse 15, 83483, Bischofswiesen, Deutschland. D.Sander@mac.com
pubmed:publicationType
Journal Article, English Abstract